RecruitingNCT07311044

CVD/PH and Voice Characteristics

Cardiovascular Disease/ Pulmonary Hypertension and Voice Characteristics Study


Sponsor

Mayo Clinic

Enrollment

7,000 participants

Start Date

Jan 8, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether voice characteristics — such as tone, rhythm, and vocal patterns captured by a voice recording — can indicate the presence of heart or lung conditions like cardiovascular disease or pulmonary hypertension (high blood pressure in the lungs). It is an observational study using voice samples from patients already having routine heart tests. **You may be eligible if...** - You are attending Mayo Clinic for a routine echocardiogram (heart ultrasound) - You have had or are scheduled for a cardiac catheterisation procedure or cardiac surgery at Mayo Clinic **You may NOT be eligible if...** - You are not attending the relevant Mayo Clinic cardiac labs Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07311044


Related Trials